Search Result "Sofosbuvir"
Ledipasvir/Sofosbuvir versus Daclatasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C Genotype 4 Patients
Journal: Current Drug Safety
Volume: 15 Issue: 1 Year: 2020 Page: 53-60
Author(s): Lamiaa N. Abdelaty,Ahmed A. Elnaggar,Amira A. Said,Raghda R.S. Hussein
Ventricular Extrasystoles after First Dose of Sofosbuvir in a Patient Treated with Propranolol but not with Amiodarone: A Case Report
Journal: Reviews on Recent Clinical Trials
Volume: 12 Issue: 3 Year: 2017 Page: 159-161
Author(s): Samir Rouabhia,Sabah Baghazza,Hamza Sadouki,Sihem Djezzar,Rafik Bencherif,Rofia Guehimeche,Mourad Sadelaoud,Djamel Mallem,Karima Chaabna
Efficacy and Safety of Sofosbuvir in the Treatment of Chronic Hepatitis C: The Dawn of a New Era
Journal: Reviews on Recent Clinical Trials
Volume: 9 Issue: 1 Year: 2014 Page: 1-7
Author(s): Ivan Gentile,Federico Borgia,Emanuela Zappulo,Antonio Riccardo Buonomo,Anna Maria Spera,Giuseppe Castaldo,Guglielmo Borgia
Sofosbuvir: Really Meets the Unmet Needs for Hepatitis C Treatment?
Journal: Infectious Disorders - Drug Targets
Volume: 20 Issue: 1 Year: 2020 Page: 2-15
Author(s): Deepti Chopra,Bharti Bhandari
Outcomes of Treatment and Predictors of Response to Sofosbuvir Plus Simeprevir in Hepatitis C Virus with Genotype-4 Infection
Journal: Infectious Disorders - Drug Targets
Volume: 20 Issue: 3 Year: 2020 Page: 389-395
Author(s): Ossama A. Ahmed,Mohamed A Elsebaey,Mohamed Hassan A. Fouad,Mahmoud Elkadeem,Rehab Badawi,Ahmed Khayyal,Shaimaa Soliman,Manal Saad Negm,Sherief Abd-Elsalam
Non-ANCA Leucocytoclasic Vasculitis Induced by Sofosbuvir/LedipasvirTreatment: A Case Report
Journal: Current Drug Safety
Volume: 19 Issue: 1 Year: 2024 Page: 145-147
Author(s):
Analytical and Bioanalytical Methods for the Quantification of the NucleotidePolymerase Inhibitor - Sofosbuvir: A Critical Review (2015-2021)
Journal: Current Pharmaceutical Analysis
Volume: 19 Issue: 1 Year: 2023 Page: 51-65
Author(s):
Validated Spectrodensitometric Method for Simultaneous Estimation of Sofosbuvir, Ribavirin and Saxagliptin in their Pure and Pharmaceutical Dosage Forms
Journal: Current Pharmaceutical Analysis
Volume: 14 Issue: 3 Year: 2018 Page: 212-218
Author(s): Salwa R. El-Shaboury,Samia M. El-Gizawy,Noha N. Atia,Mohammad Nabil Abo-Zeid
A Novel Promising Therapeutic Option Against Hepatitis C Virus: An Oral Nucleotide NS5B Polymerase Inhibitor Sofosbuvir
Journal: Current Medicinal Chemistry
Volume: 20 Issue: 30 Year: 2013 Page: 3733-3742
Author(s): I. Gentile,F. Borgia,A. R. Buonomo,G. Castaldo,G. Borgia
Efficacy of Sofosbuvir Plus Ribavirin with or Without Peginterferon- Alfa in Treatment of a Cohort of Egyptian Patients with Hepatitis C Virus Infection
Journal: Infectious Disorders - Drug Targets
Volume: 17 Issue: 2 Year: 2017 Page: 95-100
Author(s): Ossama A. Ahmed,Hany H. Kaisar,Nehad Hawash,Hossam Samir,Sherif S. T. Shabana,Mohamed Hassan A. Fouad,Fatma Rizk,Sherief Abd-Elsalam